Date / Time
The goal of this activity is to improve the knowledge, confidence, and competence of learners to integrate immune checkpoint inhibitors into the treatment of patients with SCLC.
This program is intended for physicians and other healthcare providers who care for patients with lung cancer.
Upon completion of this activity, participants should be able to:
- Describe the role of combination approaches to optimize checkpoint inhibitor efficacy and reduce treatment resistance in patients with SCLC
- Plan treatment strategies for patients with extensive-stage SCLC that include immune checkpoint inhibitor combinations
- Evaluate the available clinical data on biomarkers of response to immune checkpoint inhibitor combinations in SCLC
- Manage immune-related adverse events in patients with advanced SCLC receiving immune checkpoint inhibitor therapy
- Incorporate investigational immunotherapy-based combinations and clinical trial participation as part of clinical care strategies for patients with SCLC
Joint Accreditation Statement
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physician Continuing Medical Education
CCO designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.